2-219076341-G-A
Position:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The ENST00000356853.10(NHEJ1):c.*40C>T variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.744 in 1,613,646 control chromosomes in the GnomAD database, including 450,717 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.72 ( 40298 hom., cov: 30)
Exomes 𝑓: 0.75 ( 410419 hom. )
Consequence
NHEJ1
ENST00000356853.10 3_prime_UTR
ENST00000356853.10 3_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: -1.25
Genes affected
NHEJ1 (HGNC:25737): (non-homologous end joining factor 1) Double-strand breaks in DNA result from genotoxic stresses and are among the most damaging of DNA lesions. This gene encodes a DNA repair factor essential for the nonhomologous end-joining pathway, which preferentially mediates repair of double-stranded breaks. Mutations in this gene cause different kinds of severe combined immunodeficiency disorders. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.81).
BP6
Variant 2-219076341-G-A is Benign according to our data. Variant chr2-219076341-G-A is described in ClinVar as [Benign]. Clinvar id is 1268786.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-219076341-G-A is described in Lovd as [Benign].
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.764 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NHEJ1 | NM_024782.3 | c.*40C>T | 3_prime_UTR_variant | 8/8 | ENST00000356853.10 | NP_079058.1 | ||
NHEJ1 | NM_001377498.1 | c.*40C>T | 3_prime_UTR_variant | 8/8 | NP_001364427.1 | |||
NHEJ1 | NM_001377499.1 | c.*40C>T | 3_prime_UTR_variant | 8/8 | NP_001364428.1 | |||
NHEJ1 | NR_165304.1 | n.1118C>T | non_coding_transcript_exon_variant | 9/9 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
NHEJ1 | ENST00000356853.10 | c.*40C>T | 3_prime_UTR_variant | 8/8 | 1 | NM_024782.3 | ENSP00000349313 | P4 |
Frequencies
GnomAD3 genomes AF: 0.724 AC: 109958AN: 151806Hom.: 40287 Cov.: 30
GnomAD3 genomes
AF:
AC:
109958
AN:
151806
Hom.:
Cov.:
30
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.707 AC: 177663AN: 251122Hom.: 64107 AF XY: 0.710 AC XY: 96444AN XY: 135760
GnomAD3 exomes
AF:
AC:
177663
AN:
251122
Hom.:
AF XY:
AC XY:
96444
AN XY:
135760
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.746 AC: 1090581AN: 1461720Hom.: 410419 Cov.: 65 AF XY: 0.744 AC XY: 540898AN XY: 727168
GnomAD4 exome
AF:
AC:
1090581
AN:
1461720
Hom.:
Cov.:
65
AF XY:
AC XY:
540898
AN XY:
727168
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.724 AC: 110011AN: 151926Hom.: 40298 Cov.: 30 AF XY: 0.722 AC XY: 53572AN XY: 74246
GnomAD4 genome
AF:
AC:
110011
AN:
151926
Hom.:
Cov.:
30
AF XY:
AC XY:
53572
AN XY:
74246
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1725
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | GeneDx | Jun 23, 2018 | - - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Unidad de Genómica Garrahan, Hospital de Pediatría Garrahan | Nov 12, 2023 | This variant is classified as Benign based on local population frequency. This variant was detected in 86% of patients studied by a panel of primary immunodeficiencies. Number of patients: 83. Only high quality variants are reported. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at